Bioequivalence of a 2.5 mg Linagliptin / 500 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 500 mg Tablets Administered Together in Healthy Volunteers
PHASE1
Study to demonstrate bioequivalence of a 2.5 mg linagliptin / 500 mg metfor...
Investigation of the Metabolism and Pharmacokinetics of 10 mg [14C] BI 1356 Administered Orally Compared to 5 mg [14C] BI 1356 Administered Intravenously in Healthy Male Volunteers
PHASE1
To determine the basic pharmacokinetics of BI 1356 BS, its metabolite CD 17...
Bioavailability of Combination Tablet BI 1356/Metformin Compared With Single BI 1356 and Metformin Administered Together to Healthy Male and Female Subjects
PHASE1
The objective was to assess the relative bioavailability of a pilot scale l...